✦ LIBER ✦

Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery

✍ Scribed by T. Sans; C. Bofill; J. Joven; X. Clivillé; J.M. Simó; X. Llobet; A. Peró; J. Galbany

Book ID: 114440271
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 476 KB
Volume: 36
Category: Article
ISSN: 0372-1248
DOI: 10.1046/j.1537-2995.1996.36996420762.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of recombinant human erythrop

Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract

✍ Professor M. Braga; L. Gianotti; A. Vignali; O. Gentilini; P. Servida; C. Bordig 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 1 views

Use of recombinant human erythropoietin

Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery

✍ F. Mercuriali; G. Gualtieri; L. Sinigaglia; G. Inghilleri; E. Biffi; A. Vinci; M 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 577 KB

Two different dosing regimens of human r

Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty

✍ Melita Buljan; Damir Nemet; Branka Golubic-Cepulic; Goran Bicanic; Branko Tripko 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 306 KB

The effect of recombinant human erythrop

The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial

✍ T. H. Price; L. T. Goodnough; W. R. Vogler; R. A. Sacher; R. M. Hellman; M. F.M. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 797 KB

Improving the efficacy of preoperative a

Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: A randomized, double-blind, controlled trial of recombinant human erythropoietin

✍ Thomas H. Price; Lawrence T. Goodnough; William R. Vogler; Ronald A. Sacher; Ric 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 634 KB

A phase III trial of recombinant human e

A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy

✍ L.T. Goodnough; T.H. Price; K.D. Friedman; M. Johnston; D. Ciavarella; N. Khan; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 542 KB